カテゴリ： 世界, 消費財/食品, QYResearch

婦人科介護医薬品の世界市場2023年：避妊、婦人科感染症、女性感染症、閉経後疾患、婦人科がん、子宮内膜症

■ 英語タイトル：Global Gynecological Nursing Drugs Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8780）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8780
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：108
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[婦人科介護医薬品の世界市場2023年：避妊、婦人科感染症、女性感染症、閉経後疾患、婦人科がん、子宮内膜症]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料は婦人科介護医薬品のグローバル市場について調査・分析し、世界の婦人科介護医薬品市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（避妊、婦人科感染症、女性感染症、閉経後疾患、婦人科がん、子宮内膜症）、用途別セグメント分析（病院、研究所、診療所、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Amgen Inc.、F. Hoffmann La Roche Ltd、Novartis AG、Bayer AG、Merck & Co., Inc.、Eli Lilly and Company、Pfizer Inc.、Abbott Laboratories、AbbVie Inc.、GlaxoSmithKline Plc、AstraZeneca Plc、Lupin Limited、Johnson and Johnson、Sanofi SA、Ferring Pharmaceuticalsなどが含まれています。婦人科介護医薬品のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、婦人科介護医薬品市場規模を算出する際に考慮しました。

・婦人科介護医薬品市場の概要
- 製品の定義
- 婦人科介護医薬品の種類別セグメント
- 世界の婦人科介護医薬品市場規模：タイプ別分析（避妊、婦人科感染症、女性感染症、閉経後疾患、婦人科がん、子宮内膜症）
- 婦人科介護医薬品の用途別セグメント
- 世界の婦人科介護医薬品市場規模：用途別分析（病院、研究所、診療所、その他）
- 世界の婦人科介護医薬品市場規模予測（2018年-2029年）
- 婦人科介護医薬品の平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- 婦人科介護医薬品市場の競争状況およびトレンド

・婦人科介護医薬品の地域別市場規模
- 北米の婦人科介護医薬品市場規模（2018年-2029年）
- 米国の婦人科介護医薬品市場規模（2018年-2029年）
- ヨーロッパの婦人科介護医薬品市場規模（2018年-2029年）
- アジア太平洋の婦人科介護医薬品市場規模（2018年-2029年）
- 中国の婦人科介護医薬品市場規模（2018年-2029年）
- 日本の婦人科介護医薬品市場規模（2018年-2029年）
- 韓国の婦人科介護医薬品市場規模（2018年-2029年）
- インドの婦人科介護医薬品市場規模（2018年-2029年）
- オーストラリアの婦人科介護医薬品市場規模（2018年-2029年）
- 中南米の婦人科介護医薬品市場規模（2018年-2029年）
- 中東・アフリカの婦人科介護医薬品市場規模（2018年-2029年）

・種類別セグメント：避妊、婦人科感染症、女性感染症、閉経後疾患、婦人科がん、子宮内膜症
- 世界の婦人科介護医薬品のタイプ別販売量（2018年-2023年）
- 世界の婦人科介護医薬品のタイプ別売上（2018年-2023年）
- 世界の婦人科介護医薬品のタイプ別価格

・用途別セグメント：病院、研究所、診療所、その他
- 世界の婦人科介護医薬品の用途別販売量（2018年-2023年）
- 世界の婦人科介護医薬品の用途別売上（2018年-2023年）
- 世界の婦人科介護医薬品の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Amgen Inc.、F. Hoffmann La Roche Ltd、Novartis AG、Bayer AG、Merck & Co., Inc.、Eli Lilly and Company、Pfizer Inc.、Abbott Laboratories、AbbVie Inc.、GlaxoSmithKline Plc、AstraZeneca Plc、Lupin Limited、Johnson and Johnson、Sanofi SA、Ferring Pharmaceuticals

・産業チェーンと販売チャネルの分析
- 婦人科介護医薬品産業チェーン分析
- 婦人科介護医薬品の主要原材料
- 婦人科介護医薬品の販売チャネル
- 婦人科介護医薬品のディストリビューター
- 婦人科介護医薬品の主要顧客

・婦人科介護医薬品市場ダイナミクス
- 婦人科介護医薬品の業界動向
- 婦人科介護医薬品市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Highlights
The global Gynecological Nursing Drugs market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Gynecological Nursing Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Gynecological Nursing Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Gynecological Nursing Drugs include Amgen Inc., F. Hoffmann La Roche Ltd, Novartis AG, Bayer AG, Merck & Co., Inc., Eli Lilly and Company, Pfizer Inc., Abbott Laboratories and AbbVie Inc., etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Gynecological Nursing Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gynecological Nursing Drugs.
The Gynecological Nursing Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Gynecological Nursing Drugs market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gynecological Nursing Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Amgen Inc.
F. Hoffmann La Roche Ltd
Novartis AG
Bayer AG
Merck & Co., Inc.
Eli Lilly and Company
Pfizer Inc.
Abbott Laboratories
AbbVie Inc.
GlaxoSmithKline Plc
AstraZeneca Plc
Lupin Limited
Johnson and Johnson
Sanofi SA
Ferring Pharmaceuticals
Segment by Type
Contraception
Gynecological Infection
Female Infection
Postmenopausal Disease
Gynecological Cancer
Endometriosis
Segment by Application
Hospital
Institute of Medicine
Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gynecological Nursing Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Gynecological Nursing Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Gynecological Nursing Drugs Market Overview
1.1 Product Overview and Scope of Gynecological Nursing Drugs
1.2 Gynecological Nursing Drugs Segment by Type
1.2.1 Global Gynecological Nursing Drugs Market Value Comparison by Type (2023-2029)
1.2.2 Contraception
1.2.3 Gynecological Infection
1.2.4 Female Infection
1.2.5 Postmenopausal Disease
1.2.6 Gynecological Cancer
1.2.7 Endometriosis
1.3 Gynecological Nursing Drugs Segment by Application
1.3.1 Global Gynecological Nursing Drugs Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Institute of Medicine
1.3.4 Clinic
1.3.5 Others
1.4 Global Gynecological Nursing Drugs Market Size Estimates and Forecasts
1.4.1 Global Gynecological Nursing Drugs Revenue 2018-2029
1.4.2 Global Gynecological Nursing Drugs Sales 2018-2029
1.4.3 Global Gynecological Nursing Drugs Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Gynecological Nursing Drugs Market Competition by Manufacturers
2.1 Global Gynecological Nursing Drugs Sales Market Share by Manufacturers (2018-2023)
2.2 Global Gynecological Nursing Drugs Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Gynecological Nursing Drugs Average Price by Manufacturers (2018-2023)
2.4 Global Gynecological Nursing Drugs Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Gynecological Nursing Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gynecological Nursing Drugs, Product Type & Application
2.7 Gynecological Nursing Drugs Market Competitive Situation and Trends
2.7.1 Gynecological Nursing Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Gynecological Nursing Drugs Players Market Share by Revenue
2.7.3 Global Gynecological Nursing Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Gynecological Nursing Drugs Retrospective Market Scenario by Region
3.1 Global Gynecological Nursing Drugs Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Gynecological Nursing Drugs Global Gynecological Nursing Drugs Sales by Region: 2018-2029
3.2.1 Global Gynecological Nursing Drugs Sales by Region: 2018-2023
3.2.2 Global Gynecological Nursing Drugs Sales by Region: 2024-2029
3.3 Global Gynecological Nursing Drugs Global Gynecological Nursing Drugs Revenue by Region: 2018-2029
3.3.1 Global Gynecological Nursing Drugs Revenue by Region: 2018-2023
3.3.2 Global Gynecological Nursing Drugs Revenue by Region: 2024-2029
3.4 North America Gynecological Nursing Drugs Market Facts & Figures by Country
3.4.1 North America Gynecological Nursing Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Gynecological Nursing Drugs Sales by Country (2018-2029)
3.4.3 North America Gynecological Nursing Drugs Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Gynecological Nursing Drugs Market Facts & Figures by Country
3.5.1 Europe Gynecological Nursing Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Gynecological Nursing Drugs Sales by Country (2018-2029)
3.5.3 Europe Gynecological Nursing Drugs Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gynecological Nursing Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Gynecological Nursing Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Gynecological Nursing Drugs Sales by Country (2018-2029)
3.6.3 Asia Pacific Gynecological Nursing Drugs Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Gynecological Nursing Drugs Market Facts & Figures by Country
3.7.1 Latin America Gynecological Nursing Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Gynecological Nursing Drugs Sales by Country (2018-2029)
3.7.3 Latin America Gynecological Nursing Drugs Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gynecological Nursing Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Gynecological Nursing Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Gynecological Nursing Drugs Sales by Country (2018-2029)
3.8.3 Middle East and Africa Gynecological Nursing Drugs Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gynecological Nursing Drugs Sales by Type (2018-2029)
4.1.1 Global Gynecological Nursing Drugs Sales by Type (2018-2023)
4.1.2 Global Gynecological Nursing Drugs Sales by Type (2024-2029)
4.1.3 Global Gynecological Nursing Drugs Sales Market Share by Type (2018-2029)
4.2 Global Gynecological Nursing Drugs Revenue by Type (2018-2029)
4.2.1 Global Gynecological Nursing Drugs Revenue by Type (2018-2023)
4.2.2 Global Gynecological Nursing Drugs Revenue by Type (2024-2029)
4.2.3 Global Gynecological Nursing Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Gynecological Nursing Drugs Price by Type (2018-2029)
5 Segment by Application
5.1 Global Gynecological Nursing Drugs Sales by Application (2018-2029)
5.1.1 Global Gynecological Nursing Drugs Sales by Application (2018-2023)
5.1.2 Global Gynecological Nursing Drugs Sales by Application (2024-2029)
5.1.3 Global Gynecological Nursing Drugs Sales Market Share by Application (2018-2029)
5.2 Global Gynecological Nursing Drugs Revenue by Application (2018-2029)
5.2.1 Global Gynecological Nursing Drugs Revenue by Application (2018-2023)
5.2.2 Global Gynecological Nursing Drugs Revenue by Application (2024-2029)
5.2.3 Global Gynecological Nursing Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Gynecological Nursing Drugs Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Amgen Inc.
6.1.1 Amgen Inc. Corporation Information
6.1.2 Amgen Inc. Description and Business Overview
6.1.3 Amgen Inc. Gynecological Nursing Drugs Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Amgen Inc. Gynecological Nursing Drugs Product Portfolio
6.1.5 Amgen Inc. Recent Developments/Updates
6.2 F. Hoffmann La Roche Ltd
6.2.1 F. Hoffmann La Roche Ltd Corporation Information
6.2.2 F. Hoffmann La Roche Ltd Description and Business Overview
6.2.3 F. Hoffmann La Roche Ltd Gynecological Nursing Drugs Sales, Revenue and Gross Margin (2018-2023)
6.2.4 F. Hoffmann La Roche Ltd Gynecological Nursing Drugs Product Portfolio
6.2.5 F. Hoffmann La Roche Ltd Recent Developments/Updates
6.3 Novartis AG
6.3.1 Novartis AG Corporation Information
6.3.2 Novartis AG Description and Business Overview
6.3.3 Novartis AG Gynecological Nursing Drugs Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Novartis AG Gynecological Nursing Drugs Product Portfolio
6.3.5 Novartis AG Recent Developments/Updates
6.4 Bayer AG
6.4.1 Bayer AG Corporation Information
6.4.2 Bayer AG Description and Business Overview
6.4.3 Bayer AG Gynecological Nursing Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Bayer AG Gynecological Nursing Drugs Product Portfolio
6.4.5 Bayer AG Recent Developments/Updates
6.5 Merck & Co., Inc.
6.5.1 Merck & Co., Inc. Corporation Information
6.5.2 Merck & Co., Inc. Description and Business Overview
6.5.3 Merck & Co., Inc. Gynecological Nursing Drugs Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Merck & Co., Inc. Gynecological Nursing Drugs Product Portfolio
6.5.5 Merck & Co., Inc. Recent Developments/Updates
6.6 Eli Lilly and Company
6.6.1 Eli Lilly and Company Corporation Information
6.6.2 Eli Lilly and Company Description and Business Overview
6.6.3 Eli Lilly and Company Gynecological Nursing Drugs Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Eli Lilly and Company Gynecological Nursing Drugs Product Portfolio
6.6.5 Eli Lilly and Company Recent Developments/Updates
6.7 Pfizer Inc.
6.6.1 Pfizer Inc. Corporation Information
6.6.2 Pfizer Inc. Description and Business Overview
6.6.3 Pfizer Inc. Gynecological Nursing Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Pfizer Inc. Gynecological Nursing Drugs Product Portfolio
6.7.5 Pfizer Inc. Recent Developments/Updates
6.8 Abbott Laboratories
6.8.1 Abbott Laboratories Corporation Information
6.8.2 Abbott Laboratories Description and Business Overview
6.8.3 Abbott Laboratories Gynecological Nursing Drugs Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Abbott Laboratories Gynecological Nursing Drugs Product Portfolio
6.8.5 Abbott Laboratories Recent Developments/Updates
6.9 AbbVie Inc.
6.9.1 AbbVie Inc. Corporation Information
6.9.2 AbbVie Inc. Description and Business Overview
6.9.3 AbbVie Inc. Gynecological Nursing Drugs Sales, Revenue and Gross Margin (2018-2023)
6.9.4 AbbVie Inc. Gynecological Nursing Drugs Product Portfolio
6.9.5 AbbVie Inc. Recent Developments/Updates
6.10 GlaxoSmithKline Plc
6.10.1 GlaxoSmithKline Plc Corporation Information
6.10.2 GlaxoSmithKline Plc Description and Business Overview
6.10.3 GlaxoSmithKline Plc Gynecological Nursing Drugs Sales, Revenue and Gross Margin (2018-2023)
6.10.4 GlaxoSmithKline Plc Gynecological Nursing Drugs Product Portfolio
6.10.5 GlaxoSmithKline Plc Recent Developments/Updates
6.11 AstraZeneca Plc
6.11.1 AstraZeneca Plc Corporation Information
6.11.2 AstraZeneca Plc Gynecological Nursing Drugs Description and Business Overview
6.11.3 AstraZeneca Plc Gynecological Nursing Drugs Sales, Revenue and Gross Margin (2018-2023)
6.11.4 AstraZeneca Plc Gynecological Nursing Drugs Product Portfolio
6.11.5 AstraZeneca Plc Recent Developments/Updates
6.12 Lupin Limited
6.12.1 Lupin Limited Corporation Information
6.12.2 Lupin Limited Gynecological Nursing Drugs Description and Business Overview
6.12.3 Lupin Limited Gynecological Nursing Drugs Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Lupin Limited Gynecological Nursing Drugs Product Portfolio
6.12.5 Lupin Limited Recent Developments/Updates
6.13 Johnson and Johnson
6.13.1 Johnson and Johnson Corporation Information
6.13.2 Johnson and Johnson Gynecological Nursing Drugs Description and Business Overview
6.13.3 Johnson and Johnson Gynecological Nursing Drugs Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Johnson and Johnson Gynecological Nursing Drugs Product Portfolio
6.13.5 Johnson and Johnson Recent Developments/Updates
6.14 Sanofi SA
6.14.1 Sanofi SA Corporation Information
6.14.2 Sanofi SA Gynecological Nursing Drugs Description and Business Overview
6.14.3 Sanofi SA Gynecological Nursing Drugs Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Sanofi SA Gynecological Nursing Drugs Product Portfolio
6.14.5 Sanofi SA Recent Developments/Updates
6.15 Ferring Pharmaceuticals
6.15.1 Ferring Pharmaceuticals Corporation Information
6.15.2 Ferring Pharmaceuticals Gynecological Nursing Drugs Description and Business Overview
6.15.3 Ferring Pharmaceuticals Gynecological Nursing Drugs Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Ferring Pharmaceuticals Gynecological Nursing Drugs Product Portfolio
6.15.5 Ferring Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gynecological Nursing Drugs Industry Chain Analysis
7.2 Gynecological Nursing Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gynecological Nursing Drugs Production Mode & Process
7.4 Gynecological Nursing Drugs Sales and Marketing
7.4.1 Gynecological Nursing Drugs Sales Channels
7.4.2 Gynecological Nursing Drugs Distributors
7.5 Gynecological Nursing Drugs Customers
8 Gynecological Nursing Drugs Market Dynamics
8.1 Gynecological Nursing Drugs Industry Trends
8.2 Gynecological Nursing Drugs Market Drivers
8.3 Gynecological Nursing Drugs Market Challenges
8.4 Gynecological Nursing Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Gynecological Nursing Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Gynecological Nursing Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Gynecological Nursing Drugs Market Competitive Situation by Manufacturers in 2022
Table 4. Global Gynecological Nursing Drugs Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Gynecological Nursing Drugs Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Gynecological Nursing Drugs Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Gynecological Nursing Drugs Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Gynecological Nursing Drugs Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Gynecological Nursing Drugs, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Gynecological Nursing Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Gynecological Nursing Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Gynecological Nursing Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Gynecological Nursing Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gynecological Nursing Drugs as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Gynecological Nursing Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Gynecological Nursing Drugs Sales by Region (2018-2023) & (K Units)
Table 18. Global Gynecological Nursing Drugs Sales Market Share by Region (2018-2023)
Table 19. Global Gynecological Nursing Drugs Sales by Region (2024-2029) & (K Units)
Table 20. Global Gynecological Nursing Drugs Sales Market Share by Region (2024-2029)
Table 21. Global Gynecological Nursing Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Gynecological Nursing Drugs Revenue Market Share by Region (2018-2023)
Table 23. Global Gynecological Nursing Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Gynecological Nursing Drugs Revenue Market Share by Region (2024-2029)
Table 25. North America Gynecological Nursing Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Gynecological Nursing Drugs Sales by Country (2018-2023) & (K Units)
Table 27. North America Gynecological Nursing Drugs Sales by Country (2024-2029) & (K Units)
Table 28. North America Gynecological Nursing Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Gynecological Nursing Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Gynecological Nursing Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Gynecological Nursing Drugs Sales by Country (2018-2023) & (K Units)
Table 32. Europe Gynecological Nursing Drugs Sales by Country (2024-2029) & (K Units)
Table 33. Europe Gynecological Nursing Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Gynecological Nursing Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Gynecological Nursing Drugs Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Gynecological Nursing Drugs Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Gynecological Nursing Drugs Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Gynecological Nursing Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Gynecological Nursing Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Gynecological Nursing Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Gynecological Nursing Drugs Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Gynecological Nursing Drugs Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Gynecological Nursing Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Gynecological Nursing Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Gynecological Nursing Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Gynecological Nursing Drugs Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Gynecological Nursing Drugs Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Gynecological Nursing Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Gynecological Nursing Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Gynecological Nursing Drugs Sales (K Units) by Type (2018-2023)
Table 51. Global Gynecological Nursing Drugs Sales (K Units) by Type (2024-2029)
Table 52. Global Gynecological Nursing Drugs Sales Market Share by Type (2018-2023)
Table 53. Global Gynecological Nursing Drugs Sales Market Share by Type (2024-2029)
Table 54. Global Gynecological Nursing Drugs Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Gynecological Nursing Drugs Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Gynecological Nursing Drugs Revenue Market Share by Type (2018-2023)
Table 57. Global Gynecological Nursing Drugs Revenue Market Share by Type (2024-2029)
Table 58. Global Gynecological Nursing Drugs Price (US$/Unit) by Type (2018-2023)
Table 59. Global Gynecological Nursing Drugs Price (US$/Unit) by Type (2024-2029)
Table 60. Global Gynecological Nursing Drugs Sales (K Units) by Application (2018-2023)
Table 61. Global Gynecological Nursing Drugs Sales (K Units) by Application (2024-2029)
Table 62. Global Gynecological Nursing Drugs Sales Market Share by Application (2018-2023)
Table 63. Global Gynecological Nursing Drugs Sales Market Share by Application (2024-2029)
Table 64. Global Gynecological Nursing Drugs Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Gynecological Nursing Drugs Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Gynecological Nursing Drugs Revenue Market Share by Application (2018-2023)
Table 67. Global Gynecological Nursing Drugs Revenue Market Share by Application (2024-2029)
Table 68. Global Gynecological Nursing Drugs Price (US$/Unit) by Application (2018-2023)
Table 69. Global Gynecological Nursing Drugs Price (US$/Unit) by Application (2024-2029)
Table 70. Amgen Inc. Corporation Information
Table 71. Amgen Inc. Description and Business Overview
Table 72. Amgen Inc. Gynecological Nursing Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Amgen Inc. Gynecological Nursing Drugs Product
Table 74. Amgen Inc. Recent Developments/Updates
Table 75. F. Hoffmann La Roche Ltd Corporation Information
Table 76. F. Hoffmann La Roche Ltd Description and Business Overview
Table 77. F. Hoffmann La Roche Ltd Gynecological Nursing Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. F. Hoffmann La Roche Ltd Gynecological Nursing Drugs Product
Table 79. F. Hoffmann La Roche Ltd Recent Developments/Updates
Table 80. Novartis AG Corporation Information
Table 81. Novartis AG Description and Business Overview
Table 82. Novartis AG Gynecological Nursing Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Novartis AG Gynecological Nursing Drugs Product
Table 84. Novartis AG Recent Developments/Updates
Table 85. Bayer AG Corporation Information
Table 86. Bayer AG Description and Business Overview
Table 87. Bayer AG Gynecological Nursing Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Bayer AG Gynecological Nursing Drugs Product
Table 89. Bayer AG Recent Developments/Updates
Table 90. Merck & Co., Inc. Corporation Information
Table 91. Merck & Co., Inc. Description and Business Overview
Table 92. Merck & Co., Inc. Gynecological Nursing Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Merck & Co., Inc. Gynecological Nursing Drugs Product
Table 94. Merck & Co., Inc. Recent Developments/Updates
Table 95. Eli Lilly and Company Corporation Information
Table 96. Eli Lilly and Company Description and Business Overview
Table 97. Eli Lilly and Company Gynecological Nursing Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Eli Lilly and Company Gynecological Nursing Drugs Product
Table 99. Eli Lilly and Company Recent Developments/Updates
Table 100. Pfizer Inc. Corporation Information
Table 101. Pfizer Inc. Description and Business Overview
Table 102. Pfizer Inc. Gynecological Nursing Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Pfizer Inc. Gynecological Nursing Drugs Product
Table 104. Pfizer Inc. Recent Developments/Updates
Table 105. Abbott Laboratories Corporation Information
Table 106. Abbott Laboratories Description and Business Overview
Table 107. Abbott Laboratories Gynecological Nursing Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Abbott Laboratories Gynecological Nursing Drugs Product
Table 109. Abbott Laboratories Recent Developments/Updates
Table 110. AbbVie Inc. Corporation Information
Table 111. AbbVie Inc. Description and Business Overview
Table 112. AbbVie Inc. Gynecological Nursing Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. AbbVie Inc. Gynecological Nursing Drugs Product
Table 114. AbbVie Inc. Recent Developments/Updates
Table 115. GlaxoSmithKline Plc Corporation Information
Table 116. GlaxoSmithKline Plc Description and Business Overview
Table 117. GlaxoSmithKline Plc Gynecological Nursing Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. GlaxoSmithKline Plc Gynecological Nursing Drugs Product
Table 119. GlaxoSmithKline Plc Recent Developments/Updates
Table 120. AstraZeneca Plc Corporation Information
Table 121. AstraZeneca Plc Description and Business Overview
Table 122. AstraZeneca Plc Gynecological Nursing Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. AstraZeneca Plc Gynecological Nursing Drugs Product
Table 124. AstraZeneca Plc Recent Developments/Updates
Table 125. Lupin Limited Corporation Information
Table 126. Lupin Limited Description and Business Overview
Table 127. Lupin Limited Gynecological Nursing Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Lupin Limited Gynecological Nursing Drugs Product
Table 129. Lupin Limited Recent Developments/Updates
Table 130. Johnson and Johnson Corporation Information
Table 131. Johnson and Johnson Description and Business Overview
Table 132. Johnson and Johnson Gynecological Nursing Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Johnson and Johnson Gynecological Nursing Drugs Product
Table 134. Johnson and Johnson Recent Developments/Updates
Table 135. Sanofi SA Corporation Information
Table 136. Sanofi SA Description and Business Overview
Table 137. Sanofi SA Gynecological Nursing Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Sanofi SA Gynecological Nursing Drugs Product
Table 139. Sanofi SA Recent Developments/Updates
Table 140. Ferring Pharmaceuticals Corporation Information
Table 141. Ferring Pharmaceuticals Description and Business Overview
Table 142. Ferring Pharmaceuticals Gynecological Nursing Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Ferring Pharmaceuticals Gynecological Nursing Drugs Product
Table 144. Ferring Pharmaceuticals Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Gynecological Nursing Drugs Distributors List
Table 148. Gynecological Nursing Drugs Customers List
Table 149. Gynecological Nursing Drugs Market Trends
Table 150. Gynecological Nursing Drugs Market Drivers
Table 151. Gynecological Nursing Drugs Market Challenges
Table 152. Gynecological Nursing Drugs Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Gynecological Nursing Drugs
Figure 2. Global Gynecological Nursing Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Gynecological Nursing Drugs Market Share by Type in 2022 & 2029
Figure 4. Contraception Product Picture
Figure 5. Gynecological Infection Product Picture
Figure 6. Female Infection Product Picture
Figure 7. Postmenopausal Disease Product Picture
Figure 8. Gynecological Cancer Product Picture
Figure 9. Endometriosis Product Picture
Figure 10. Global Gynecological Nursing Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 11. Global Gynecological Nursing Drugs Market Share by Application in 2022 & 2029
Figure 12. Hospital
Figure 13. Institute of Medicine
Figure 14. Clinic
Figure 15. Others
Figure 16. Global Gynecological Nursing Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Gynecological Nursing Drugs Market Size (2018-2029) & (US$ Million)
Figure 18. Global Gynecological Nursing Drugs Sales (2018-2029) & (K Units)
Figure 19. Global Gynecological Nursing Drugs Average Price (US$/Unit) & (2018-2029)
Figure 20. Gynecological Nursing Drugs Report Years Considered
Figure 21. Gynecological Nursing Drugs Sales Share by Manufacturers in 2022
Figure 22. Global Gynecological Nursing Drugs Revenue Share by Manufacturers in 2022
Figure 23. The Global 5 and 10 Largest Gynecological Nursing Drugs Players: Market Share by Revenue in 2022
Figure 24. Gynecological Nursing Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 25. Global Gynecological Nursing Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 26. North America Gynecological Nursing Drugs Sales Market Share by Country (2018-2029)
Figure 27. North America Gynecological Nursing Drugs Revenue Market Share by Country (2018-2029)
Figure 28. United States Gynecological Nursing Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Canada Gynecological Nursing Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Europe Gynecological Nursing Drugs Sales Market Share by Country (2018-2029)
Figure 31. Europe Gynecological Nursing Drugs Revenue Market Share by Country (2018-2029)
Figure 32. Germany Gynecological Nursing Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. France Gynecological Nursing Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. U.K. Gynecological Nursing Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Italy Gynecological Nursing Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Russia Gynecological Nursing Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Asia Pacific Gynecological Nursing Drugs Sales Market Share by Region (2018-2029)
Figure 38. Asia Pacific Gynecological Nursing Drugs Revenue Market Share by Region (2018-2029)
Figure 39. China Gynecological Nursing Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Japan Gynecological Nursing Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. South Korea Gynecological Nursing Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. India Gynecological Nursing Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Australia Gynecological Nursing Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. China Taiwan Gynecological Nursing Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Indonesia Gynecological Nursing Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Thailand Gynecological Nursing Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Malaysia Gynecological Nursing Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Latin America Gynecological Nursing Drugs Sales Market Share by Country (2018-2029)
Figure 49. Latin America Gynecological Nursing Drugs Revenue Market Share by Country (2018-2029)
Figure 50. Mexico Gynecological Nursing Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Brazil Gynecological Nursing Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Argentina Gynecological Nursing Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Middle East & Africa Gynecological Nursing Drugs Sales Market Share by Country (2018-2029)
Figure 54. Middle East & Africa Gynecological Nursing Drugs Revenue Market Share by Country (2018-2029)
Figure 55. Turkey Gynecological Nursing Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Saudi Arabia Gynecological Nursing Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. UAE Gynecological Nursing Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. Global Sales Market Share of Gynecological Nursing Drugs by Type (2018-2029)
Figure 59. Global Revenue Market Share of Gynecological Nursing Drugs by Type (2018-2029)
Figure 60. Global Gynecological Nursing Drugs Price (US$/Unit) by Type (2018-2029)
Figure 61. Global Sales Market Share of Gynecological Nursing Drugs by Application (2018-2029)
Figure 62. Global Revenue Market Share of Gynecological Nursing Drugs by Application (2018-2029)
Figure 63. Global Gynecological Nursing Drugs Price (US$/Unit) by Application (2018-2029)
Figure 64. Gynecological Nursing Drugs Value Chain
Figure 65. Gynecological Nursing Drugs Production Process
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Distributors Profiles
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 循環器疾患看護薬の世界市場2023年：降圧薬、抗狭心症薬、抗凝固薬、抗高脂血症薬、抗心不全薬、抗不整脈薬
  • 麻薬の世界市場2023年：ファストスリープニュー、保定寧混合物、ルミアンバオ、その他複合麻酔薬
  • MET阻害薬の世界市場2023年：C-Met生物学的阻害剤、低分子C-Met阻害剤、C-Metアンタゴニスト抗体、HGFアンタゴニスト抗体、クリングルバリアントアンタゴニスト
  • 婦人科機器のグローバル市場（2022年-2029年）：手術機器、ハンドヘルド機器、画像診断システム
  • ペット用駆虫薬の世界市場2023年：体外駆虫薬、生体内駆虫薬
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8780 )"婦人科介護医薬品の世界市場2023年：避妊、婦人科感染症、女性感染症、閉経後疾患、婦人科がん、子宮内膜症" (英文：Global Gynecological Nursing Drugs Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。